GILDER GAGNON HOWE & CO LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 195 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,347,000
-25.5%
179,090
-0.5%
0.02%
-25.0%
Q2 2022$1,809,000
-26.2%
179,966
-9.1%
0.03%
+39.1%
Q1 2022$2,450,000
-45.1%
197,935
+1.4%
0.02%
-8.0%
Q4 2021$4,466,000
+5.5%
195,283
+2.1%
0.02%
+13.6%
Q3 2021$4,234,000
+71.4%
191,314
+0.4%
0.02%
+83.3%
Q2 2021$2,470,000
+2.9%
190,565
+3.1%
0.01%
-7.7%
Q1 2021$2,400,000
-3.7%
184,825
+2.5%
0.01%
+8.3%
Q4 2020$2,493,000180,2500.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders